INS and Alzheimer disease: Recent research has increasingly focused on exploring the link between insulin signaling and AD, demonstrating cognitive improvements in patients with minor cognitive dysfunction and AD, following the use of antihyperglycemic agents including metformin, intranasal insulin, incretins, and thiazolidinediones.